Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2003-03-12
2008-08-12
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C530S356000, C530S840000
Reexamination Certificate
active
07410770
ABSTRACT:
A method for improving the diagnostic assessment of cartilage degenerative processes, and to provide means of monitoring the effects of therapeutical measures taken towards arthritic diseases in most mammals utilizes an immunoassay to detect fragments of collagen type II resulting from collagenase activity comprising an antibody directed against an epitope comprised in the amino acid sequence HRGYPGLDG, located in the helical region of collagen type II.
REFERENCES:
patent: 5641837 (1997-06-01), Eyre
patent: 5919634 (1999-07-01), Eyre
patent: 6132976 (2000-10-01), Poole et al.
patent: 6342361 (2002-01-01), Qvist et al.
patent: 7148020 (2006-12-01), Holmdahl et al.
patent: WO01/38872 (2001-05-01), None
Harlow et al. Antibodies: A Laboratory Manual (1988) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 72-76.
Kuby, Immunology, W.H. Freeman and Company (1992), p. 125.
Janeway et al. Immunobiology: the Immune System in Health and Disease (1999), Elsevier Science Ltd/Garland Publishing, New York, NY, Fourth Edition, pp. 34-35.
Deberg et al., “One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression” Osteoarthritis and Cartilage (2005).
Billinghurst et al, J. Clin Invest, vol. 99, No. 7, Apr. 1997, pp. 1534-1545, Enhanced Cleavage of Type II Collagen by . . .
Croucher et al, J Clin Pathol Mol Pathol, 52, 1999, pp. 323-331 Differential detection of type II collagen N-terminal and . . .
Dodge et al, J. Clin. Invest., vol. 83, Feb 1989, pp. 647-661, Immunohistochemical Detection and Immunochemical Analysis of . . .
Furumitsu et al, Jour of Rheumatology, 27, 2000, pp. 64-70, Levels of Serum and Synovial Fluid Pyridinium Crosslinks in . . .
Henrotin et al, XP-002258974, Type II Collagen Derived Fragment (Coll 2-1) is New Marker Predictive of Osteoarthritis . . .
Hollander et al, J. Clin. Invest., vol. 93, Apr. 1994, pp. 1722-1732, Increased Damage to Type II Collagen in . . .
Wollheim, APMIS 104, pp. 81-93, 1996, Predictors of joint damage in rheumatoid arthritis.
Soinila et al, Jour of Histochem and Cytochem, vol. 40, No. 2, pp. 231-239, 1992, Immunohistochemistry of Enkephalins: . . .
Moller, Scand J Clin Lab Invest, 58, 1998, pp. 269-278, Connective tissue markers of rheumatoid arthritis.
Christgau Stephan
Deberg Michelle
Henrotin Yves
Reginster Jean-Yves
Foster Christine
Jacobson & Holman PLLC
Le Long V.
Universite De Liege
LandOfFree
Method for monitoring collagen type II degradation in cartilage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for monitoring collagen type II degradation in cartilage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for monitoring collagen type II degradation in cartilage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4005722